Since 2010, Oncotarget has been publishing its weekly articles concerning the latest in oncology studies and findings to the medical community at large. While the primary focus is cancer-oriented, other related subjects are allowed. Other topics such as Cardiology, Neuropathology/Neuroscience, Cell and Mol Biology, Pharmacology, Gerotarget/Aging, Endocrinology, and Metabolism are normal subjects that relate.
The editorial board at http://endnote.com/downloads/style/oncotarget, headed by Andrei V. Gudkov and Mikhail V. Blagosklonny, of the Roswell Park Cancer Institute of Buffalo, New York, oversees all submissions for publication. The key factor in acceptance is the merit the content has in its subject field and its uniqueness. There is no point in publishing something that is nothing more that a previous theme with window dressing.
A good example of what is considered unique is a recent publication on scijournal.org that reported that vaping mechanisms had a significant role in the onset of a certain gum disorder resulting from their use. Documentation and citations correlated with usage of vaping and the activity itself was the incriminating factor, not the vaping devices themselves.
Authors submit their articles to the Editorial Board of Oncotarget to be reviewed and evaluated on Facebook.com. The system of evaluation consists of a peer review system where no fewer than two reviewers participate. The reviewing editors must be experts at the level of the author or the subject matter. The value of two or more reviewers gives credibility to verification and more than a voice in the discussion.
It is essential that the focus of articles is strictly on the subject matter and that it is presented in a clear format on Bioxbio.com with proper citations and developmental organization that is logical to follow to its conclusion.
There is no room for any digression into politics, innuendo, slander, debasement, opinion or philosophy, gender or sexual orientation, and other distractions which will add nothing to the thesis at hand.
Authors are also advised to have the means of keeping raw data available for years if need be, as there may be an occasion to refer to it at a later date. In essence, the subject of the presentation should be direct and to the point, and supportive evidence and proofs should leave no other conclusion.
Oncotarget encourages interested professionals and researchers to submit articles because of the nature of the disease of cancer. The timely release of relevant and documented evidence has many times turned the tide with even the most insidious of cancers.